PI
XFOR icon

PEAK6 Investments’s X4 Pharmaceuticals XFOR Stock Holding History

PEAK6 Investments’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$199 – 5060
2022
Q4 		$199 Buy
+7
New +$332 ﹤0.01% 4320

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PEAK6 Investments's XFOR Position: Q3 2024 in Review

PEAK6 Investments held its X4 Pharmaceuticals (XFOR) position steady in Q3 2024 at 333 shares worth $6.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

PEAK6 Investments first reported a position in XFOR in Q3 2022 and has held it in 7 quarters since. The position peaked at $103K in Q3 2022. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2024.

  • PEAK6 Investments held 333 shares of X4 Pharmaceuticals worth $6.69K as of Q3 2024.
  • PEAK6 Investments left its X4 Pharmaceuticals share count unchanged in Q3 2024.
  • X4 Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3254 holding.
  • PEAK6 Investments first reported a position in X4 Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
  • PEAK6 Investments's X4 Pharmaceuticals position peaked at $103K in Q3 2022.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.